Sep 07, 2023 / 04:45PM GMT
Derek Archila - Wells Fargo - Analyst
All right. Thank you. I think we'll get started here with the afternoon session at the Wells Fargo Healthcare Conference. My name is Derek Archila. I'm one of the biotech analysts here at Wells. Very excited to have our next fireside discussion with Kezar Life Sciences. So from the company, we have Noreen Henig. She is the Chief Medical Officer of the company. So Noreen, thanks for joining us.
Noreen Henig - Kezar Life Sciences, Inc. - Chief Medical Officer
Thank you for having me.
Derek Archila - Wells Fargo - Analyst
Awesome. Maybe just to start off, give us a little bit of background about Kezar and then maybe kind of, again, state of the business right now in terms of like where you are, what you're working on, and then we can dig into some of the questions here.
Noreen Henig - Kezar Life Sciences, Inc. - Chief Medical Officer
Sure. So Kezar Life Sciences is a biotech. We're headquartered in the San Francisco Bay area. We're
Kezar Life Sciences Inc at Wells Fargo Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot